Goal of the analysis:
Determine whether a software product qualifies as a medical device under relevant regulations and evaluate cybersecurity vulnerabilities that could impact patient safety, data integrity, or device functionality. Ensure alignment with regulatory guidelines (for example, FDA SaMD guidance, IEC 62304, ISO 14971, and applicable cybersecurity standards).
Data required:
- Software functionality and intended use statements
- Regulatory definitions of Software as a Medical Device for target markets (for example, FDA, EU MDR)
- Software architecture and design documentation
- Network and communication protocols used by the software (for example, Wi-Fi, Bluetooth, cloud connectivity)
- Current cybersecurity measures (for example, encryption, authentication, secure boot)
- Risk management documentation (FMEAs, hazard analyses) and known cybersecurity frameworks (for example, NIST Cybersecurity Framework)
- Records of previous cybersecurity incidents or vulnerabilities
Detailed step-by-step instruction on how to conduct the analysis:
- Determine SaMD classification. Compare software functionality and intended use against regulatory criteria to confirm if it qualifies as a medical device. Identify applicable risk classifications (for example, Class I, II, or III in the US; Class I, IIa, IIb, or III in the EU).
- Outline device functionality and data flows. Document software inputs, outputs, data storage, and any connections to external systems (for example, EHRs, cloud servers).
- Identify potential cybersecurity threats. Consider threats such as unauthorized access, data tampering, denial of service, malware injections, and third-party vulnerabilities.
- Assess severity and likelihood of attacks. Rate the impact on patient safety, data confidentiality, and software performance if security is compromised. Use established risk analysis methods (for example, CVSS scoring or hazard-based FMEA).
- Review existing cybersecurity controls. Evaluate encryption methods, access controls, patch management processes, and incident response plans. Check for compliance with standards like ISO 27001 or other industry best practices.
- Identify and prioritize risk mitigation actions. For high-risk vulnerabilities, propose measures such as multi-factor authentication, secure communication protocols, secure coding practices, and more frequent security audits.
- Document risk-benefit analysis. Demonstrate that residual cybersecurity risks are acceptable given the clinical benefits of the SaMD.
- Develop a monitoring and update plan. Outline a process for ongoing vulnerability scans, software patches, and updates to maintain robust cybersecurity as threats evolve.
- Summarize findings. Compile a final assessment report detailing device classification, identified risks, mitigation strategies, and recommended best practices for cybersecurity lifecycle management.
Format of the output of analysis:
- A written SaMD determination report clarifying regulatory classification
- A cybersecurity risk assessment matrix (likelihood vs. impact) identifying high-priority threats
- A compliance checklist mapping existing controls to relevant guidelines and standards
- An action plan with timelines and responsibilities for implementing additional security measures
- An executive summary highlighting key risks, mitigation steps, and overall cybersecurity readiness
How to interpret results:
- Clear alignment with regulatory definitions of SaMD confirms the need to follow medical device regulations, including risk management, software validation, and post-market surveillance.
- High-risk vulnerabilities or repeated findings of inadequate controls signal immediate need for stronger cybersecurity measures.
- Established monitoring and update plans indicate a proactive stance, essential for managing rapidly evolving threats.
Steps a company can take to improve on this measure:
- Engage cybersecurity experts and conduct regular penetration testing to uncover vulnerabilities.
- Adopt secure development life cycle (SDLC) practices, including code reviews, threat modeling, and automated security testing.
- Implement robust user authentication, encryption, and secure data transfer protocols.
- Collaborate with external partners (for example, cloud service providers) to ensure all integrated systems meet cybersecurity requirements.
- Maintain a continuous post-market surveillance program to address new threats, patch vulnerabilities promptly, and communicate risks to stakeholders.
Request the PDF Download of How to Analyze a Medical Devices Company
Menu of the analyses:
Table of Contents
A. Regulatory & Compliance
- Regulatory Pathway Analysis
- Regulatory Compliance and Quality Management Systems Review
- Labeling and Unique Device Identification (UDI) Compliance Assessment
- Device Classification and Product Code Analysis
- Combination Product Regulatory Strategy
- EU MDR/IVDR Compliance Gap Analysis
- MDSAP (Medical Device Single Audit Program) Readiness and Gap Analysis
- OTC vs. Prescription Device Classification Feasibility
- Reprocessing and Re-Manufacturing Compliance Assessment
- Software Update Lifecycle (IEC 62304) Compliance Review
B. Clinical & Post-Market
- Clinical Evidence Review
- Post-Market Surveillance and Vigilance
- CRO and Clinical Site Management Efficiency Analysis
- Real-World Evidence Generation Strategy for Device Performance
- Clinical Evidence Gap Analysis
- Comparative Efficacy and Safety Benchmarking vs. Standard of Care
- Field Safety Corrective Action and Recall Readiness Evaluation
- Patient Engagement and Compliance Tracking for Home-Use Devices
C. Reimbursement & Market Access
D. Product Development & Lifecycle
E. Operations & Supply Chain
F. Risk Management & Quality
G. Commercial Strategy & Marketing
H. Technology & Innovation
- Software as a Medical Device (SaMD) and Cybersecurity Risk Assessment
- Device Tracking and Traceability Program Analysis
- Human Factors Engineering and Usability Evaluation
- Material Compatibility and Biomaterial Selection Analysis
- Clinical Data Integration with Wearables and IoT Devices
- Calibration and Maintenance Program for Reusable Devices
- In-Vitro Diagnostic (IVD) Connectivity with Laboratory Information Systems (LIS) Workflow Analysis
- Remote Servicing and Maintenance Approach for Connected Medical Devices
I. Intellectual Property
J. Sustainability & Environmental Impact